Matthew J. Dowd and Hon. Paul R. Michel (Ret.) Discuss Biotech Patent Eligibility

In a recent IPWatchdog article, Judge Paul R. Michel (Ret.) and Matthew J. Dowd revisit the landmark Diamond v. Chakrabarty decision and its relevance to today’s biotech innovations. The article analyzes the Federal Circuit appeal in Regenxbio v. Sarepta, where the court must decide whether a man-made host cell qualifies as patent eligible under Section 101. Drawing on precedent from Chakrabarty and Myriad, Dowd and Judge Michel emphasize why maintaining strong patent protections is critical for advancing life-saving technologies. The full article can be found here.